Corporate News     15-May-24
Lupin achieves ISO 14001 and ISO 45001 certification
For its manufacturing sites, R&D center and corporate office

Lupin announced that all 12 of its manufacturing sites, its R&D Center and corporate office in India have successfully completed rigorous audits and been certified by DNV for ISO 14001 — Environment Management Systems (EMS), and ISO 45001 — Occupational Health and Safety Management System (OHSMS). This achievement marks a significant milestone in acknowledging Lupin's commitment to safe and sustainable operations.

ISO 14001 is an internationally recognized standard for Environmental Management Systems. This certification demonstrates Lupin's dedication to minimizing its environmental footprint and fostering sustainable practices across its operations. The ISO 45001 certification underscores Lupin's unwavering commitment to ensuring the health, safety and well-being of its employees and stakeholders.

Previous News
  Lupin launches Rivaroxaban drug in US
 ( Hot Pursuit - 10-Mar-25   10:02 )
  Lupin launches Rivaroxaban Tablets USP, 2.5 mg in the US
 ( Corporate News - 07-Mar-25   16:43 )
  Lupin Ltd spurts 0.59%, up for five straight sessions
 ( Hot Pursuit - 06-Mar-25   13:00 )
  Lupin allots 59,940 equity shares under ESOP
 ( Corporate News - 27-Feb-25   12:40 )
  Indices drift lower in early trade; breadth weak
 ( Market Commentary - Mid-Session 24-Feb-25   09:34 )
  Stock Alert: Granules India, Lupin, Bharti Airtel, Hazoor Multi Projects, Lemon Tree Hotels
 ( Market Commentary - Stock Alert 24-Feb-25   08:22 )
  Lupin gets EIR from USFDA for New Jersey facility
 ( Hot Pursuit - 22-Feb-25   10:41 )
  Lupin receives EIR for its Somerset facility
 ( Corporate News - 21-Feb-25   18:12 )
  Lupin receives 'A-' leadership rating from CDP
 ( Corporate News - 19-Feb-25   15:15 )
  Aurobindo Pharma Ltd Falls 6.07%, BSE Healthcare index Drops 2.12%
 ( Hot Pursuit - 19-Feb-25   09:30 )
  Lupin
 ( Results - Analysis 12-Feb-25   13:32 )
Other Stories
  Mercury Trade Links to conduct EGM
  15-Mar-25   20:06
  Galada Finance to conduct board meeting
  15-Mar-25   20:06
  Board of Galaxy Surfactants recommends interim dividend
  15-Mar-25   16:12
  Heads UP Ventures announces board meeting date
  15-Mar-25   16:12
  Savera Industries to conduct board meeting
  15-Mar-25   16:12
  Strides Pharma Science announces acquisition of Singapore-based Amexel
  15-Mar-25   15:45
  Mphasis allots 99,115 equity shares under ESOP
  15-Mar-25   15:43
  Shilpa Pharma Lifesciences' Unit-2 clear USFDA inspection
  15-Mar-25   15:40
  Wipro grants 9,868 RSUs under ESOP
  15-Mar-25   15:39
  New Delhi Television announces resignation of director
  15-Mar-25   15:38
Back Top